Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALMOTRIPTAN MALATE Cause Condition aggravated? 13 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Condition aggravated have been filed in association with ALMOTRIPTAN MALATE (Almotriptan Malate). This represents 2.6% of all adverse event reports for ALMOTRIPTAN MALATE.

13
Reports of Condition aggravated with ALMOTRIPTAN MALATE
2.6%
of all ALMOTRIPTAN MALATE reports
0
Deaths
11
Hospitalizations

How Dangerous Is Condition aggravated From ALMOTRIPTAN MALATE?

Of the 13 reports, 11 (84.6%) required hospitalization.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALMOTRIPTAN MALATE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does ALMOTRIPTAN MALATE Cause?

Drug ineffective (266) Hyperhidrosis (258) Nightmare (243) Sedation (243) Nausea (236) Nephrolithiasis (216) Off label use (178) Product use in unapproved indication (157) Drug dose omission (52) Product used for unknown indication (38)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which ALMOTRIPTAN MALATE Alternatives Have Lower Condition aggravated Risk?

ALMOTRIPTAN MALATE vs ALOE VERA LEAF ALMOTRIPTAN MALATE vs ALOGLIPTIN ALMOTRIPTAN MALATE vs ALOGLIPTIN\METFORMIN ALMOTRIPTAN MALATE vs ALOGLIPTIN\PIOGLITAZONE ALMOTRIPTAN MALATE vs ALOSETRON

Related Pages

ALMOTRIPTAN MALATE Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated ALMOTRIPTAN MALATE Demographics